← brief for 2026-08-10 · Slowing decline

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Key takeaways

This trial tests a drug called AP306 to lower high phosphate levels in the blood of adults on dialysis. High phosphate is a common and harmful problem in kidney failure. The study checks safety and how well it works, and there are no results yet.

Who did this work

Run by R1 Therapeutics.
Sites: Apogee Clinical Research, LLC · California Institute of Renal Research · Academic Medical Research Institute · North America Research Institute · Colorado Kidney Care · DaVita Clinical Research

Source

Trial registration · ClinicalTrials.gov — CKD recruiting · 2026-08-03
https://clinicaltrials.gov/study/NCT06712654